search button
Open Access

LncRNA GASL1 inhibits growth and promotes expression of apoptosis‑associated proteins in prostate carcinoma cells through GLUT‑1

  • Authors:
    • Zhiqin Li
    • Hong Liu
    • Wen Ju
    • Yifei Xing
    • Xiaoping Zhang
    • Jun Yang

  • View Affiliations

  • Published online on: April 12, 2019     https://doi.org/10.3892/ol.2019.10244
  • Pages: 5327-5334

  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Growth‑arrest‑associated long non‑coding (lnc)RNA 1 (GASL1) is as newly identified lncRNA that is associated with liver cancer. The present study aimed to investigate the role of GASL1 in prostate carcinoma (PC). Expression levels of GASL1 in prostate tissues and sera from patients with PC and from healthy subjects were detected by reverse transcription‑quantitative polymerase chain reaction. Receiver operating characteristic and survival curve analyses were performed to evaluate the diagnostic and prognostic values of GASL1 for patients with PC. A GASL1 expression vector was transfected into PC cells prior to assessment of cell proliferation and expression of B cell lymphoma 2 (Bcl‑2) and glucose transporter 1 (GLUT‑1) by Cell Counting Kit‑8 and western blotting, respectively. The results demonstrated that GASL1 was significantly downregulated in the tissue and serum of patients with PC compared to those of healthy subjects. In addition, GASL1 was used to distinguish patients with PC from healthy controls, and low expression levels of GASL1 were associated with short survival time. Expression levels of GASL1 were significantly associated with tumor size. GASL1 overexpression inhibited PC cell growth. Overexpression of GASL1 upregulated Bcl‑2 expression and downregulated GLUT‑1 expression. In conclusion, these data suggested that lncRNA GASL1 may inhibit PC cell proliferation by targeting GLUT‑1.
View Figures
View References

Related Articles

Journal Cover

June-2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Liu H, Ju W, Xing Y, Zhang X and Yang J: LncRNA GASL1 inhibits growth and promotes expression of apoptosis‑associated proteins in prostate carcinoma cells through GLUT‑1. Oncol Lett 17: 5327-5334, 2019.
APA
Li, Z., Liu, H., Ju, W., Xing, Y., Zhang, X., & Yang, J. (2019). LncRNA GASL1 inhibits growth and promotes expression of apoptosis‑associated proteins in prostate carcinoma cells through GLUT‑1. Oncology Letters, 17, 5327-5334. https://doi.org/10.3892/ol.2019.10244
MLA
Li, Z., Liu, H., Ju, W., Xing, Y., Zhang, X., Yang, J."LncRNA GASL1 inhibits growth and promotes expression of apoptosis‑associated proteins in prostate carcinoma cells through GLUT‑1". Oncology Letters 17.6 (2019): 5327-5334.
Chicago
Li, Z., Liu, H., Ju, W., Xing, Y., Zhang, X., Yang, J."LncRNA GASL1 inhibits growth and promotes expression of apoptosis‑associated proteins in prostate carcinoma cells through GLUT‑1". Oncology Letters 17, no. 6 (2019): 5327-5334. https://doi.org/10.3892/ol.2019.10244